Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.

Journal: Neuron

Published: 2020-05-03

DOI: 10.1016/j.neuron.2020.04.011

Affiliations: 26

Authors: 35

Go to article
Institutions Share
Department of Cell Biology, Emory University, United States of America (USA) 0.14
Mayo Clinic Department of Neuroscience, Florida Campus, United States of America (USA) 0.13
Department of Neurology, Emory University, United States of America (USA) 0.09
School of Medicine, Emory University, United States of America (USA) 0.08
Department of Pharmacology and Chemical Biology, Emory University, United States of America (USA) 0.07
Galician Health Service (SERGAS), Spain 0.07
Department of Neurology and Neuroscience, Okayama University, Japan 0.06
USC University Hospital Complex (CHUS), Spain 0.05
Mayo Clinic Graduate School of Biomedical Sciences, United States of America (USA) 0.04
Department of Psychiatry and Behavioral Sciences, Emory University, United States of America (USA) 0.04
Fujimoto General Hospital (FGH), Japan 0.03
Department of Neurosurgery, Emory University, United States of America (USA) 0.03
UCLA David Geffen School of Medicine (DGSOM), United States of America (USA) 0.03
USC Health Research Institute of Santiago de Compostela (IDIS), Spain 0.03
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain 0.02
Complejo Hospitalario Universitario de Vigo (CHUVI), Spain 0.02
Galicia Sur Health Research Institute (IISGS), Spain 0.02
Wallace H. Coulter Department of Biomedical Engineering (BME), United States of America (USA) 0.02
Lyon University Hospital (HCL), France 0.01
Claude Bernard University Lyon 1 (UCBL), France 0.01
Department of Neuroscience, UF, United States of America (USA) 0.01
Center for Translational Research in Neurodegenerative Disease (CTRND), UF, United States of America (USA) 0.01
Norman Fixel Institute for Neurological Diseases, UF, United States of America (USA) 0.01

Return